Skip to Content

A/P 25/45 (Alogliptin Benzoate and Pioglitazone Hydrochloride 25 mg / 45 mg)

Pill with imprint A/P 25/45 is Red, Round and has been identified as Alogliptin Benzoate and Pioglitazone Hydrochloride 25 mg / 45 mg. It is supplied by Perrigo New York Inc..

Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 25 mg / 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A/P 25/45

Alogliptin Benzoate and Pioglitazone Hydrochloride

Imprint:
A/P 25/45
Strength:
25 mg / 45 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Perrigo New York Inc.
National Drug Code (NDC):
45802-0499

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide